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Introduction
Although our understanding of pain and effective 
pain management has increased greatly over the last 
decade, many patients still suffer from unmanage-
able chronic pain and many patients still experience 
post-operative hyperalgesia and suboptimal pain 
control (Wilder-Smith & Arendt-Nielsen 2006). 
Animal pain studies have greatly contributed to our 
understanding of acute and chronic pain process-
ing. They resulted in validated and reproducible 
analgesiometric animal tests for research and de-
velopment of new analgesics for patients, but also 
were accompanied by suffering in a large number of 
animals in these tests. An optimal balance between 
scientific progress and animal welfare is of utmost 
importance.
The acceptance of animal experiments by the public 
is strongly related to the degree of animal suffering. 
This acceptance has been the subject of several polls 
in European countries over the last decade (MORI / 
Medical Research Council 1999;Intomart GfK / The 
Dutch Society for the Protection of Animals, 2004; 
MORI / Coalition for Medical Progress, 2002; 
MORI / Coalition for Medical Progress, 2005). 
A reduction in the degree of animal suffering in an-
algesiometric tests can be achieved by the use of an-
aesthesia as a refinement. The attained improvement 
in animal welfare by the use of anaesthesia would 
be welcomed by both researchers and the general 
public as long as the validity of the analgesiometric 
tests remains.  Refinement is one of the three Rs 
(Replacement, Reduction and Refinement) criteria 
as first described in “ The Principles of Humane 
Experimental Technique” (Russell & Burch, 1959). 
The pain research community has adapted these 
principles with the publication of the International 
Association for the Study of Pain (IASP) guidelines 
(Zimmermann, 1983). 
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Currently, analgesiometric tests frequently use pain 
related (reflex) behaviour as the primary outcome 
and therefore require conscious animals. The debate 
on optimal choice of behavioural pain tests has been 
broadened by Vierck et al. (2008), who encourage 
the use of complex behavioural tests for pain assess-
ment. Within the context of the high attrition rate of 
drugs at the preclinical / clinical interface, the in-
troduction of complex behavioural tests in the pre-
clinical phase may improve the translational validity 
of preclinical phase tests. At the moment, however, 
analgesiometric reflex tests are still performed in 
large numbers of animals by pharmaceutical com-
panies and the search for alternatives therefore is 
very relevant.
Analgesiometric tests with an optimal animal wel-
fare profile would use unconscious animals and 
non-invasive techniques. Unconsciousness would 
prevent animals from experiencing pain. Non-
invasive techniques would minimize discomfort in 
the animals after recovery from the analgesiometric 
tests. The possibility to reuse the same animals for 
different tests of different drugs would also greatly 
reduce the number of required animals.
Analgesiometric tests in unconscious animals with 
an optimal scientific profile would provide either the 
same (reflex) behaviour as under conscious condi-
tions or a useful alternative measure for pain related 
behaviour. Relevant alternative objective measures 
could be EEG or fMRI (measurement of blood 
oxygenation changes in the brain by MRI), both 
non-invasive approaches, or by monitoring c-fos (a 
protein marker of neuronal activity monitored by 
immunohistochemical staining). For EEG, a review 
on refinement options, including the minimal anaes-
thesia model, has recently been published (Murrell 
& Johnson, 2006). Therefore, this review will focus 
only on c-fos and fMRI as alternative measures for 
(reflex) pain related behaviour.
The aim of this review is firstly to present an over-
view of the influence of anaesthesia on pain related 
reflex behaviour and on c-fos or functional MRI as 
alternative measures in analgesiometric tests. Sec-
ondly, the implications for animal welfare from the 
use of anaesthesia in analgesiometric tests will be 
described.
Analgesiometric tests overview
Analgesiometric tests each have their specific scien-
tific and welfare characteristics (Table 1). Pain test-
ing characteristics include the applied stimulus, the 
measured response and the applicability for differ-
ent types of analgesics. Animal welfare characteris-
tics include group size and level of discomfort. 
Anaesthesia may influence the outcome of analge-
siometric tests. When this influence is present, it is 
important to find out whether this influence improves 
or reduces the translational validity of the tests. In 
general, the translational validity to humans of an-
algesiometric tests during anaesthesia in animals is 
indicated by the extent to which analgesic dosages 
in the animal test correlate with the required dosages 
for analgesic effects in humans. Anaesthetic influ-
ence on pain models depends largely on the chosen 
outcome measure. Reflex behaviour like a with-
drawal reflex will be less susceptible to anaesthetic 
influence and thus a possible target for refinement 
than higher order behaviour like aggression. When 
other response functions than behaviour are chosen 
as the outcome measure, anaesthetic influence again 
depends on the particular experimental setup. For 
example, neural activation as represented by spinal 
c-fos expression may still be present although pain 
behaviour has disappeared or vice versa. Therefore, 
different measures for analgesiometric tests will 
be discussed in relation to anaesthetic influence on 
testing results.
Anaesthesia effects on pain related behaviour and 
neural c-fos expression
Several inhalation anaesthetics have been used in 
published pain test studies, including halothane, 
isoflurane and sevoflurane. Halothane is a halogen 
substituted ethane and more or less comparable to 
chloroform, a halogen substituted methane, while 
isoflurane and sevoflurane are halogenated ethers. 
These different molecular structures can result in 
distinctive anaesthetic/analgetic properties and spe-
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cific effects in pain tests.
When both inhalation anaesthetics and injection an-
aesthetics are equally suitable for analgesiometric 
testing, the preference should go to inhalation an-
aesthetics because of better pharmacokinetic control 
of the administration. Modern inhalation anaesthet-
ics like isoflurane and sevoflurane have the advan-
tage that pharmacokinetics are very stable in time 
and metabolism is minimal. This stability results in 
a robust level of anaesthesia. Injection anaesthetics 
have the disadvantage that plasma concentrations 
are likely to increase over time. Their pharmacoki-
netics are also more likely to interact with the phar-
macokinetics of the analgesic study drug.
Halothane is a suitable anaesthetic for the study of 
spinal reflexes e.g. the withdrawal reflex and spinal 
neural activity as marked e.g. by c-fos expression. 
Halothane may under certain conditions even im-
prove the sensitivity to detect nociceptive (mechani-
cal) neural responses (c-fos) in rats (Novikova et 
al., 2004). Halothane does not influence tail flick 
testing of morphine when used at moderate dosages 
(Goto et al., 1996). In the formalin test, halothane 
alone does not influence spinal c-fos expression 
and in combination with nitrous oxide it is suitable 
to reduce discomfort by anaesthesia during phase 
I and subsequently let the animal recover to study 
phase II flinching and licking behaviour (O’Connor 
& Abram, 1995).
Isoflurane does not influence the analgesic effect of 
morphine on tail flick tests (Goto et al., 1996), but 
dose-dependently antagonizes nitrous oxide analgesia.
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Table 1. Analgesiometric test characteristics summary
Model Stimulus Type* Duration Escape Discomfort Response** Refs
Tail flick Thermal TH Short Yes Low Reflex W (D’Amour & Smith, 
1941)
Tail immersion Thermal SM Short Yes Low Reflex W (Farre et al., 1989)
Paw flick Thermal TH Short Yes Low Reflex W (Hargreaves et al., 
1988)
Paw pressure Mechanical TH Short Yes Low Reflex W
Short Electric 
Tail Stimulation
Electrical SM Short No Medium Complex TEVD (Charpentier 1961; 
Jourdan et al., 
1995)
Electric Train 
Tail Stimulation
Electrical SM Medium No Medium Complex WV (Carroll & Lim, 
1960; Borszcz et 
al., 1994)
Electric Train
Paw Stimulation 
(NIWR)
Electrical SM Medium No Medium Reflex W (Duysens & Gybels, 
1988; Matsumoto 
et al., 2006)
Formalin paw 
test
Chemical SM Long No High Reflex FL (Dubuisson & Den-
nis, 1977; Vissers et 
al., 2006)
Writhing test Chemical SM Long No High Reflex Wr (Siegmund et al., 
1957)
* TH: Threshold; SM: Supramaximal
** D: Defence; E: Escape; F: Flinching; L: Licking; T: Twitching; V: Vocalisation; W: Withdrawal; Wr: Writhing;
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Sevoflurane at light anaesthesia levels can be used 
to quantitatively measure the withdrawal reflex in 
the hindpaw noxious induced withdrawal reflex 
(NIWR) model, but dose dependently reduces this 
reflex (van den Broek et al., 2006).
Urethane is a suitable anaesthetic for the study of 
normal physiology. Despite its carcinogenic proper-
ties, it is frequently used for terminal physiologi-
cal measurements. Reflex behaviour can also be 
reproduced under anaesthesia for the paw flick test 
(Yeomans et al., 1996; Yeomans & Proudfit, 1994) 
in the rat, but tail flick latencies are fully suppressed 
in mice (Banks et al., 1988b). These observed as-
say influences may not only be related to species, 
but also to dose. In general, spinal mechanisms are 
still intact under light urethane anaesthesia and this 
provides a good starting point for other spinally me-
diated reflexes and measures of (nociceptive) neural 
activity. However, not only clinical signs of inflam-
matory pain, including swelling and edema, but 
also spinal c-fos expression are strongly decreased 
by urethane in the carrageenan hindpaw inflamma-
tion model (Buritova & Besson, 2001) compared to 
conscious animals (Buritova & Besson, 1998) for 
NSAIDs like flurbiprofen.
Propofol has strong excitatory effects on ascending 
nociceptive pathways, autonomic and stress-related 
functions (Kubota et al., 2007). These excitatory 
effects may be related to the fact that intravenous 
propofol injection can be painful. Despite this ob-
servation, propofol can be used as an anaesthetic to 
study brain activation after heat stimulation (Kubota 
et al., 2007), although pentobarbital anaesthesia re-
sults in larger brain activation (Kubota et al., 2007). 
Propofol anaesthesia cannot be used to measure 
tail flick latencies (Sawamura et al., 2004). Only 
sedative dosages (6 mg/kg/hr) combined with ni-
trous oxide 75% result in a detectable, although still 
strongly increased (40% maximum possible effect), 
tail flick latency. Propofol can be used to measure 
the hindpaw withdrawal reflex in the NIWR model 
at low continuous infusion rates, but dose-depend-
ently reduces this reflex at higher infusion rates or 
intermittent boluses (Dirksen et al., 1997).
Pentobarbital can be used as an anaesthetic to study 
heat induced c-fos activation in the brain (Kubota et 
al., 2007) at a medium dosage (60 mg/kg/hr). Tail 
flick latencies in mice are unaffected under pento-
barbital anaesthesia. Unfortunately, the sensitivity 
of the tail flick test for opioids is also decreased. 
However, in mice latency effects of non-opioid an-
algesics like serotonin (5HT
2
-receptor mediated) 
can be measured more sensitively in the tail flick 
assay under pentobarbital anaesthesia than under 
conscious conditions (Banks et al., 1988a). In the 
latter study, the increased sensitivity under anaes-
thesia can be attributed to an increased response 
combined with a decreased group variation.
Anaesthesia effects on functional MRI pain studies
Functional MRI is an important complementary tool 
to evaluate the analgesic efficacy and mechanisms 
of candidate drugs (Negus et al., 2006) for classical 
pain testing. An attractive feature of functional MRI 
experiments is the possibility of repeated measure-
ment in the same animals. This reduces variability 
in longitudinal studies and reduces the number of 
animals required, although individual discomfort 
increases. This review focuses on acute pain; fMRI 
representations of persistent, chronic pain have been 
reviewed elsewhere (Verne et al., 2004). 
The majority of experimental functional MRI stud-
ies in animals are currently performed under anaes-
thesia, for obvious reasons. The first studies used 
alpha-chloralose, but new alternatives that provide 
promising results include isoflurane. The number of 
experimental functional MRI pain/nociception stud-
ies is limited and mainly performed under anaes-
thesia. The number of functional human MRI pain 
studies is extensive and mainly under conscious 
conditions. Both animal and human pain studies are 
of interest to evaluate the effects of anaesthesia in 
animal experiments and the extrapolation of their 
results to pain in humans.
In conscious humans, functional imaging of brain 
responses to acute pain were reviewed in a meta-
analysis (Peyron et al., 2000) and newer publications 
were recently summarized (Borsook & Becerra, 
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2006). These publications showed that frequently 
activated brain areas in humans fMRI and PET 
studies are located in the anterior cingulate, second-
ary somatic and insular cortical regions and with 
slightly less consistency in the contralateral thala-
mus and primary somatic area. Lateral thalamus, 
primary (SI) and secondary (SII) somatosensory 
cortex and insula are mainly involved in sensory-
discriminative nociceptive processing, while the 
medial thalamus and the anterior cingulate cortex 
(ACC) are mainly involved in affective-motivation-
al nociceptive processing (Wiech et al., 2001). Ac-
tivation of pain control areas in the brain stem like 
the periaqueductal gray are not always present, but 
are fairly frequent.
In fMRI pain studies in laboratory animals, anaes-
thesia is often a mandatory prerequisite. The so-
matosensory cortex is still activated by stimulation 
under anaesthetic conditions. This is true for both 
noxious and non-noxious stimulations (Masamo-
to et al., 2007;Chang & Shyu, 2001; Lowe et al., 
2007). The comparability of blood-oxygen-level 
dependent fMRI (BOLD) activation depends on the 
stimulation protocol used and has to be optimized 
for each anaesthetic (Masamoto et al., 2007). It is 
clear that BOLD responses after stimulation are 
attenuated by anaesthesia, e.g. the hypercapnic 
response is reduced under 1% and 2% isoflurane 
(Sicard et al., 2003). Whether this attenuation also 
influences BOLD responses to noxious stimulation 
is less clear. Volatile anaesthetics increase cerebral 
blood flow compared to opioids or pentobarbital 
(Hendrich et al., 2001). Hence, the choice of vola-
tile anaesthetic dosage will determine the sensitivity 
of the fMRI measurement.
In rats, functional imaging of brain responses to 
acute pain stimuli is mostly performed under an-
aesthesia. A summary of the activated brain areas is 
presented in Table 2. A full comparison with human 
publications is not achievable, since the majority of 
animal publications include only particular regions 
of the brain in the functional imaging setup.
Alpha-chloralose is frequently used in fMRI stud-
ies. It has some negative properties (Silverman & 
Muir, III, 1993), including poor solubility, slow 
pharmacokinetics, development of metabolic aci-
dosis and hyperreactivity to auditory stimulation. 
Apart from these side-effects, it can only be used in 
terminal experiments, because it also induces peri-
tonitis and adynamic ileus. These properties should 
be taken into consideration when fMRI pain stud-
ies are interpreted. Alpha-chloralose use in the cap-
saicin hyperalgesia model resulted in spinal dorsal 
horn activation after injection in the hindpaw (Mal-
isza et al., 2003b) or the forepaw (Malisza & Stro-
man, 2002). Brain studies demonstrated activation 
of the somatosensory cortex, the motor cortex, the 
frontal cortex and the cingulate cortex after injec-
tion in the hindpaw (Malisza et al., 2003a) or the 
forepaw (Malisza & Docherty, 2001).  In the latter 
study, subsequent morphine application resulted in 
decreased activity in frontal and cingulate cortex. 
In the formalin model, alpha-chloralose has been 
used to map brain activity. The same areas as in the 
capsaicin model demonstrated a positive BOLD 
response after formalin application in the forepaw 
and this response was reduced by pre-application 
of morphine (Tuor et al., 2000). In a second study, 
the nociceptive specific effects were separated from 
fMRI effects caused by increases in blood pressure 
(Tuor et al., 2002); especially fMRI effects during 
the first five minutes after formalin injection are 
correlated with blood pressure increases. Noxious 
electrical stimulation of the sciatic nerve led to a 
BOLD increase not only of the somatosensory and 
cingulate cortex, but also medial thalamic and hy-
pothalamic activations were detected (Chang & 
Shyu, 2001); the activation in all four areas was 
significantly suppressed by prior morphine ap-
plication. This finding of morphine suppression is 
in concordance with Tuor et al. (Tuor et al., 2000; 
Chang & Shyu, 2001); however, the somatosensory 
cortex activity did not decrease after morphine ap-
plication, but activity of all regions decreased after 
nitrous oxide inhalation in that study.
Isoflurane has an interesting set of properties for 
fMRI studies compared to alpha-chloralose. It has 
fast pharmacokinetics in combination with an easily 
Table 2. Activated spinal and brain areas in functional MRI animal nociception studies
Mode of 
Stimulation
Stimulation 
details
Reference Anaesthesia DH PB PG HT T HC A S1 S2 M I C FC RS
Spinal studies
Chemical formalin (Porszasz et 
al., 1997)
Iso/N
2
O 1,0/67 % 
insp
+
Chemical capsaicin (Malisza et 
al., 2003b)
Iso/Air 1.5 % insp >
-Chloralose 
80+40mg/kg IV
+
Chemical capsaicin (Malisza & 
Stroman, 
2002)
Iso/Air 1.5 % insp >
-Chloralose 
80+40mg/kg IV
+
Brain studies
Thermal X (Hess et al., 
2007)
Iso/Air 1-2 % insp + + L+ 
M
+ + + + + +
Chemical capsaicin (Moylan 
Governo et 
al., 2006)
Iso/N
2
O 1.5/65 % 
insp
+ + + + +
Chemical Capsaicin (Malisza & 
Docherty, 
2001)
Iso/Air 1.5 % insp >
-Chloralose 
80+40mg/kg IV
+ + + +
Chemical capsaicin (Malisza et 
al., 2003a)
Iso/Air 1.5 % insp >
-Chloralose 
80+40mg/kg IV
+ + + +
Chemical formalin (Yu et al., 
2007)
Propofol 250 mg/
kg IP
+
Chemical formalin (Shah et al., 
2005)
Halo/N
2
O 1-2/70 
% insp
+ + + + + +
Chemical formalin (Tuor et al., 
2002)
Iso/Air 1.5 % insp >
-Chloralose 
80+40mg/kg IV
+ + + + + +
Chemical +
Electrical
formalin (Tuor et al., 
2000)
Iso/Air 1.5 % insp >
-Chloralose 
80+40mg/kg IV
+ + + +
Electrical non+ nox-
ious
(Chang & 
Shyu, 2001)
Iso/Air 1.5 % insp >
-Chloralose 
80+40mg/kg IV
+ + + + +
Electrical non+ nox-
ious
(Lowe et al., 
2007; Chang 
& Shyu, 2001)
Halo/? 3 > 
-Chloralose 60+25 
mg/kg IV
+ + + + +
DH: spinal dorsal horn; S1, S2: primary and secondary somatosensory cortex; M: motor cortex; I: insular 
cortex; C: cingulated cortex; FC: (pre)frontal cortex; PB: parabrachial nucleus; T: thalamus; HT: hypo-
thalamus; HC: hippocampus; PG: periaqueductal gray; RS: retrosplenial cortex; A: amygdale
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Table 2. Activated spinel and brain areas in functional MRI animal nociception studies
DH: spinal dorsal horn; S1, S2: primary and secondary somatosensory cortex; M: motor cortex; I: insular 
cortex; C: cingulated cortex; FC: (pre)frontal cortex; PB: parabrachial nucleus; T: thalamus; HT: hypo-
thalamus; HC: hippocampus; PG: periaqueductal gray; RS: retrosplenial cortex; A: amygdala
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accessible administration route, provides adequate 
muscle relaxation, maintains the acid-base balance 
and is very suitable for repeated measurements. 
Furthermore, as its (end-) expiratory concentration 
can be measured on-line, it is easier to maintain 
constant levels of anaesthesia. At the minimal al-
veolar inhalation anaesthetic concentration for iso-
flurane (1 MAC
50
 ~1.45%), flow-metabolism cou-
pling of the cortex persists (Hansen et al., 1989). 
Therefore, it promises to be a suitable alternative 
candidate for fMRI studies. Indeed, it has been 
used in a number of fMRI pain studies in rats in an 
air/oxygen or nitrous oxide/oxygen mixture. Most 
studies mentioned above under alpha-chloralose 
used isoflurane during the preparation phase of the 
experiment. Isoflurane  (in N
2
O/O
2
) use in the for-
malin test resulted in spinal dorsal horn activation 
(Porszasz et al., 1997); this activation was blocked 
by local lidocaine application. In a recent article, 
capsaicin noxious activation in the brain was in-
vestigated (Moylan Governo et al., 2006); several 
subcortical regions responded to the noxious stimu-
lation, including periaqueductal gray, hypothalamus 
and thalamus and the parabrachial and hippocampal 
areas. The activation of most areas increased by su-
perimposed mechanical stimulation after capsaicin 
application, although periaqueductal gray activation 
decreased (Moylan Governo et al., 2006). Finally, 
Hess et al. used isoflurane in air. They found an 
activation of many cortical brain regions (Hess et 
al. 2007), including somatosensory, motor, insular, 
cingulate, retrosplenial, and subcortical brain re-
gions, including lateral and medial thalamus, hypo-
thalamus and the periaqueductal gray. Pre-treatment 
with zymosan in the latter study (Hess et al., 2007) 
increased noxious heat BOLD effects.
Halothane effects on fMRI are comparable with 
those of alpha-chloralose and isoflurane. In the 
formalin test, activation was found in the cortical 
areas, including somatosensory and cingulate cor-
tex and subcortical areas, including thalamus, hypo-
thalamus, periaqueductal gray and amygdala (Shah 
et al., 2005). After electrical noxious stimulation, 
cortical and thalamic activation was demonstrated 
(Lowe et al., 2007).
Propofol was only used in one formalin pain study. 
It was applied in a non-standard way (250 mg/kg 
IP) and resulted in amygdala activation (Yu et al., 
2007)
Anaesthesia recommendations for analgesiometric 
tests
In this review, it was demonstrated that the use 
of anaesthetics in pain research is feasible, espe-
cially in the first phase of preclinical analgesic as-
sessment. This will reduce the number of animals 
necessary for subsequent pain testing in conscious 
animals. It is very likely that the use of anaesthet-
ics in pain research will contribute significantly to 
the welfare of laboratory animals in analgesiometric 
tests. However, it should be realized that fMRI un-
der anaesthesia provides mostly information about 
nociception rather than pain. 
It is important to realize that there is a limited num-
ber of studies that compare both the conscious re-
sponse and a response under anaesthetic conditions. 
Also, studies that compare two different anaesthet-
ics within the same study are generally not avail-
able. Therefore, preliminary anaesthetic recommen-
dations for the analgesiometric tests below should 
be used cautiously and further research is required 
to provide evidence based recommendations.
Tail flick testing can be performed under anaes-
thetic conditions. A low dosage of isoflurane is a 
good anaesthetic choice for opioid analgesia test-
ing, since it does not influence morphine tail flick 
latencies (Goto et al., 1996). We recommend a dos-
age of 1.5% to minimize anaesthetic influence on 
analgesiometric results.
Electrical noxious stimulation can be performed 
under anaesthetic conditions, if noxious reflex test-
ing is performed. For integrated, higher order be-
haviour like vocalisation afterdischarges or defence 
behaviour, conscious animals are still needed.
Formalin testing may be performed under anaes-
thetic conditions with the combination of halothane 
and nitrous oxide to reproduce flinching and lick-
ing behaviour during the second phase (O’Connor 
Scand. J. Lab. Anim. Sci. 2009 Vol. 36 No. 3
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& Abram, 1995). Thiopental is another possibility. 
Halothane alone only mildly influences spinal c-
fos expression in the formalin test. Alternative ap-
proaches with different anaesthetics to detect neural 
activation are described under fMRI studies.
Anaesthesia recommendations for c-fos and fMRI 
nociceptive testing
The feasibility to use anaesthetics in nociceptive 
neural activation c-fos studies depends on the an-
algesic group of interest and the chosen baseline 
anaesthesia. Some studies have described uncou-
pling of behaviour and spinal Fos-IR. This requires 
further investigation. One solution may be to find a 
correlation between behaviour and neural activation 
in brain nuclei, to explain the observed discrepancy 
between c-fos and pain behaviour.
The use of anaesthetics in functional MRI pain stud-
ies depends on the research question. There may be 
a difference in brain activation between isoflurane 
and alpha-chloralose fMRI studies, both frequently 
used in functional MRI studies. Somatomotor, cin-
gulate and frontal cortex activation was found in 
formalin studies with alpha-chloralose. Comparable 
studies with isoflurane are currently lacking, so it 
is not clear whether isoflurane in the formalin test 
would result in the same pattern of brain activation. 
From thermal and electrical stimulation studies, it 
is clear that under isoflurane anaesthesia, activation 
of these areas is possible and also of the thalamus, 
hypothalamus and periaqueductal gray. Activation 
of these latter subcortical nuclei has not yet been 
found under alpha-chloralose anaesthesia.
In this review, publications are referred to that 
demonstrate the feasibility of anaesthesia in com-
bination with pain/nociceptive testing. However, the 
number of publications that compared the results 
of analgesiometric tests under conscious condi-
tions with anaesthetic conditions for a broad range 
of analgesic agents is still very limited. Therefore, 
further research on analgesiometric tests under an-
aesthetic conditions is necessary to validate these 
recommendations.
Conclusions
Every anaesthetic has its particular sites of action 
in the central nervous system. These sites of anaes-
thetic action determine whether components of the 
pain system remain unaffected, are unresponsive or 
hyperresponsive and whether the application of the 
anaesthetic leads to meaningful results. Apart from 
the anaesthetic action, the interaction between an-
aesthetic and analgesic agents is important for the 
interpretation of the results. The analgesic agents 
also have points of analgesic action that can be in-
fluenced by the anaesthetic used.  For the proper 
validation of the feasibility of anaesthetics in anal-
gesiometric tests, it is therefore not only necessary 
to demonstrate sufficient sensitivity of the response 
function of the test, but also to demonstrate that an-
algesic effects on the response function can be mea-
sured in a reliable and sensitive way.
Reflex behaviour like the tail flick and withdrawal 
reflexes and nociceptive processing, including c-fos 
and functional MRI, can be studied best with low 
dosage isoflurane. 
For more complex behaviour, the use of anaesthetics 
is not suitable because they impair higher cognitive 
functioning. This is mainly related to the necessity 
to be conscious to express e.g. aggressive behaviour 
and partly related to the disturbance of nocicep-
tive processing that anaesthetics have on different 
supraspinal levels. However, in the future, it may 
become possible to predict the outcome of complex 
(pain) behaviour in conscious animals from the re-
sults of neural activity measurements like c-fos or 
fMRI in particular brain nuclei in anesthetized ani-
mals. This approach would require a large number 
of validation studies to prove the predictive value 
of neural activity for pain behaviour outcome, but 
would be very beneficial for the anesthetized ani-
mals in terms of discomfort reduction. 
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